LUCID CAPITAL MARKETS initiates coverage on Rithm Property with Buy rating, $3 PT.
ByAinvest
Tuesday, Sep 9, 2025 10:35 am ET1min read
RPT--
Rithm Property has seen its shares surge 77.45% over the past year, driven by positive developments in the market. The company's Contractor Advisory Committee (CAC) meeting with MolDX resulted in a positive outlook, with panelists emphasizing the effectiveness of Rithm's diagnostic tools in improving patient triage capabilities. The meeting also highlighted the potential for insurance coverage expansion, which could be a major catalyst for the company's shares.
In addition to the CAC meeting, Rithm Property reported its second-quarter 2025 financial results, showing a revenue of $1.2 million, which marks a 19% increase compared to the previous year. This revenue figure surpassed the FactSet consensus estimate of $1.1 million but did not meet Cantor Fitzgerald's projection of $1.5 million. The company's earnings per share (EPS) came in at -$0.10, slightly better than the anticipated -$0.11.
The investment research firm also noted the ongoing interest and analysis from other investment firms regarding Rithm Property's financial performance and future prospects. BTIG has raised its price target for Rithm Property to $2.50, maintaining a Buy rating after a positive meeting with the Centers for Medicare & Medicaid Services (CMS) regarding Medicare coverage for the company's diagnostic tests. Meanwhile, Cantor Fitzgerald reiterated its Overweight rating with a $3.00 price target, reflecting confidence in the company's growth trajectory.
Lucid Capital Markets' analysis highlights the potential for significant upside in Rithm Property's shares, given the positive developments in the market and the company's strong financial position. The firm's Buy rating and $3.00 price target suggest that investors should consider Rithm Property as a potential investment opportunity in the real estate sector.
References:
https://www.investing.com/news/analyst-ratings/needham-reiterates-buy-rating-on-lucid-diagnostics-stock-after-positive-cac-meeting-93CH-4226423
https://www.investing.com/news/analyst-ratings/lucid-diagnostics-stock-rises-as-canaccord-reiterates-buy-rating-93CH-4226228
https://www.ainvest.com/news/lucid-strategic-ecosystem-play-uber-300m-injection-reshape-autonomous-mobility-2509/
LUCID CAPITAL MARKETS initiates coverage on Rithm Property with Buy rating, $3 PT.
Lucid Capital Markets has initiated coverage on Rithm Property with a Buy rating and a price target of $3.00. The investment research firm highlighted the potential for growth and the favorable market conditions that Rithm Property is poised to benefit from. Lucid Capital Markets emphasized the company's strong financial position and the potential for significant upside in the real estate sector.Rithm Property has seen its shares surge 77.45% over the past year, driven by positive developments in the market. The company's Contractor Advisory Committee (CAC) meeting with MolDX resulted in a positive outlook, with panelists emphasizing the effectiveness of Rithm's diagnostic tools in improving patient triage capabilities. The meeting also highlighted the potential for insurance coverage expansion, which could be a major catalyst for the company's shares.
In addition to the CAC meeting, Rithm Property reported its second-quarter 2025 financial results, showing a revenue of $1.2 million, which marks a 19% increase compared to the previous year. This revenue figure surpassed the FactSet consensus estimate of $1.1 million but did not meet Cantor Fitzgerald's projection of $1.5 million. The company's earnings per share (EPS) came in at -$0.10, slightly better than the anticipated -$0.11.
The investment research firm also noted the ongoing interest and analysis from other investment firms regarding Rithm Property's financial performance and future prospects. BTIG has raised its price target for Rithm Property to $2.50, maintaining a Buy rating after a positive meeting with the Centers for Medicare & Medicaid Services (CMS) regarding Medicare coverage for the company's diagnostic tests. Meanwhile, Cantor Fitzgerald reiterated its Overweight rating with a $3.00 price target, reflecting confidence in the company's growth trajectory.
Lucid Capital Markets' analysis highlights the potential for significant upside in Rithm Property's shares, given the positive developments in the market and the company's strong financial position. The firm's Buy rating and $3.00 price target suggest that investors should consider Rithm Property as a potential investment opportunity in the real estate sector.
References:
https://www.investing.com/news/analyst-ratings/needham-reiterates-buy-rating-on-lucid-diagnostics-stock-after-positive-cac-meeting-93CH-4226423
https://www.investing.com/news/analyst-ratings/lucid-diagnostics-stock-rises-as-canaccord-reiterates-buy-rating-93CH-4226228
https://www.ainvest.com/news/lucid-strategic-ecosystem-play-uber-300m-injection-reshape-autonomous-mobility-2509/

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet